Adagio Medical Holdings Files for IPO
Ticker: ADGM · Form: S-1 · Filed: Jan 14, 2025 · CIK: 2006986
| Field | Detail |
|---|---|
| Company | Adagio Medical Holdings, INC. (ADGM) |
| Form Type | S-1 |
| Filed Date | Jan 14, 2025 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $10.00, $24.00, $0.0001, $11.56, $31,312,102 |
| Sentiment | neutral |
Sentiment: neutral
Topics: ipo, registration-statement, medical-devices
TL;DR
Adagio Medical Holdings is going public, get ready for some new medtech stock.
AI Summary
Adagio Medical Holdings, Inc. filed an S-1 form on January 14, 2025, to register its securities for a potential initial public offering. The company, formerly known as Aja Holdco, Inc. until January 4, 2024, is based in Laguna Hills, California, and operates in the surgical and medical instruments sector. This filing indicates the company is preparing to access public markets, though specific financial details and offering size are not yet detailed in this initial document.
Why It Matters
This S-1 filing signals Adagio Medical Holdings' intention to become a publicly traded company, which could bring new investment and scrutiny to the medical device sector.
Risk Assessment
Risk Level: medium — As an S-1 filing, it represents a company in the process of going public, which inherently carries risks associated with market reception and early-stage public company performance.
Key Numbers
- 373 — Public Document Count (Indicates the volume of documents associated with this filing.)
- 429 — References (Number of references within the filing, suggesting complexity.)
Key Players & Entities
- Adagio Medical Holdings, Inc. (company) — Filer of the S-1 registration statement
- Aja Holdco, Inc. (company) — Former name of Adagio Medical Holdings, Inc.
- 20250114 (date) — Filing date of the S-1 form
- 20240104 (date) — Date of company name change
- Laguna Hills, CA (location) — Business and mailing address of the company
FAQ
What is the primary business of Adagio Medical Holdings, Inc.?
Adagio Medical Holdings, Inc. operates in the Surgical & Medical Instruments & Apparatus industry, as indicated by its SIC code 3841.
When did Adagio Medical Holdings, Inc. change its name?
The company changed its name from Aja Holdco, Inc. on January 4, 2024.
What is the filing date of this S-1 form?
The S-1 form was filed on January 14, 2025.
Where is Adagio Medical Holdings, Inc. located?
The company's business and mailing address is 26051 Merit Circle, Suite 102, Laguna Hills, CA 92653.
What is the SEC file number for this registration?
The SEC file number for this S-1 registration is 333-284263.
Filing Stats: 4,577 words · 18 min read · ~15 pages · Grade level 17.7 · Accepted 2025-01-14 06:28:45
Key Financial Figures
- $10.00 — tible notes, with a conversion price of $10.00 per share, subject to adjustment (the "
- $24.00 — Common Stock, with an exercise price of $24.00 per share (the " Warrants "), issued pu
- $0.0001 — 31,818,653 shares of our common stock, $0.0001 par value per share (the " Common Stock
- $11.56 — at a redemption price of approximately $11.56 per share, for an aggregate redemption
- $31,312,102 — gate redemption amount of approximately $31,312,102. This offering involves the potential s
- $1.00 — ted sales price of our Common Stock was $1.00 per share. We are an "emerging growth
Filing Documents
- adgm-20240930xs1.htm (S-1) — 10269KB
- adgm-20240930xex5d1.htm (EX-5.1) — 17KB
- adgm-20240930xex23d2.htm (EX-23.2) — 4KB
- adgm-20240930xex23d3.htm (EX-23.3) — 4KB
- adgm-20240930xex23d4.htm (EX-23.4) — 3KB
- adgm-20240930xexfees.htm (EX-FILING FEES) — 39KB
- adgm-20240930xex5d1001.jpg (GRAPHIC) — 5KB
- adgm-20240930xs1015.jpg (GRAPHIC) — 23KB
- adgm-20240930xs1017.jpg (GRAPHIC) — 25KB
- adgm-20240930xs1019.jpg (GRAPHIC) — 48KB
- adgm-20240930xs1021.jpg (GRAPHIC) — 63KB
- adgm-20240930xs1022.jpg (GRAPHIC) — 26KB
- adgm-20240930xs1023.jpg (GRAPHIC) — 17KB
- adgm-20240930xs1024.jpg (GRAPHIC) — 49KB
- adgm-20240930xs1026.jpg (GRAPHIC) — 33KB
- adgm-20240930xs1027.jpg (GRAPHIC) — 40KB
- adgm-20240930xs1029.jpg (GRAPHIC) — 45KB
- adgm-20240930xs1030.jpg (GRAPHIC) — 40KB
- adgm-20240930xs1032.jpg (GRAPHIC) — 29KB
- adgm-20240930xs1033.jpg (GRAPHIC) — 65KB
- adgm-20240930xs1034.jpg (GRAPHIC) — 36KB
- adgm-20240930xs1036.jpg (GRAPHIC) — 44KB
- adgm-20240930xs1044.jpg (GRAPHIC) — 9KB
- adgm-20240930xs1045.jpg (GRAPHIC) — 17KB
- 0001104659-25-003193.txt ( ) — 54200KB
- adgm-20240930.xsd (EX-101.SCH) — 255KB
- adgm-20240930_cal.xml (EX-101.CAL) — 108KB
- adgm-20240930_def.xml (EX-101.DEF) — 2002KB
- adgm-20240930_lab.xml (EX-101.LAB) — 1173KB
- adgm-20240930_pre.xml (EX-101.PRE) — 2760KB
- adgm-20240930xs1_htm.xml (XML) — 8238KB
Risk Factors
Risk Factors 11 Market and Industry Data 54
Use of Proceeds
Use of Proceeds 55 Determination of Offering Price 56 Market Information for Securities and Dividend Policy 57 Unaudited Pro Forma Condensed Combined Financial Information 58
Management's Discussion and Analysis of Financial Condition and Results of Operations of ARYA
Management's Discussion and Analysis of Financial Condition and Results of Operations of ARYA 66
Management's Discussion and Analysis of Financial Condition and Results of Operations of Adagio Medical
Management's Discussion and Analysis of Financial Condition and Results of Operations of Adagio Medical 82
Management's Discussion and Analysis of Financial Condition and Results of Operations of Adagio Holdings
Management's Discussion and Analysis of Financial Condition and Results of Operations of Adagio Holdings 101
Business
Business 122 Management 151
Executive Compensation
Executive Compensation 158 Certain Relationships and Related Party Transactions 163 Principal Stockholders 166 Selling Stockholders 168 Description of our Securities 170 Material U.S. Federal Income Tax Consequences 176 Plan of Distribution 179 Legal Matters 181 Experts 181 Where You Can Find More Information 182 You should rely only on the information contained in this prospectus, any supplement to this prospectus or in any free writing prospectus, filed with the Securities and Exchange Commission. Neither we nor the selling stockholders have authorized anyone to provide you with additional information or information different from that contained in this prospectus filed with the Securities and Exchange Commission. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. The selling stockholders are offering to sell, and seeking offers to buy, our securities only in jurisdictions where offers and sales are permitted. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of our securities. Our business, financial condition, results of operations and prospects may have changed since that date. For investors outside of the United States: Neither we nor the selling stockholders, have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of our securities and the distribution of this prospectus outside the United States. i Table of Contents FREQUENTLY USED TERMS " Adagio Holdings " or " Company " means Adagio Medical Holdings, Inc., a Delaware corporation,